We are upgrading the repository! A content freeze is in effect until December 6, 2024. New submissions or changes to existing items will not be allowed during this period. All content already published will remain publicly available for searching and downloading. Updates will be posted in the Website Upgrade 2024 FAQ in the sidebar Help menu. Reach out to escholarship@umassmed.edu with any questions.

Show simple item record

Immunology. The shape of things to come

dc.contributor.authorFitzgerald, Katherine A
dc.contributor.authorGolenbock, Douglas T.
dc.date2022-08-11T08:09:10.000
dc.date.accessioned2022-08-23T16:20:17Z
dc.date.available2022-08-23T16:20:17Z
dc.date.issued2007-06-16
dc.date.submitted2011-03-25
dc.identifier.citationScience. 2007 Jun 15;316(5831):1574-6. <a href="http://dx.doi.org/10.1126/science.1144483">Link to article on publisher's site</a>
dc.identifier.issn0036-8075 (Linking)
dc.identifier.doi10.1126/science.1144483
dc.identifier.pmid17569850
dc.identifier.urihttp://hdl.handle.net/20.500.14038/35247
dc.description.abstractMechanistic understanding of how ligands can fine-tune the immune response may lead to better vaccine adjuvants.
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=17569850&dopt=Abstract">Link to Article in PubMed</a>
dc.relation.urlhttp://dx.doi.org/10.1126/science.1144483
dc.subjectAdaptor Proteins, Signal Transducing
dc.subjectAdaptor Proteins, Vesicular Transport
dc.subject*Adjuvants, Immunologic
dc.subjectAnimals
dc.subjectCrystallography, X-Ray
dc.subjectGlycolipids
dc.subjectHumans
dc.subjectHydrophobic and Hydrophilic Interactions
dc.subjectLigands
dc.subjectLipid A
dc.subjectLymphocyte Activation
dc.subjectLymphocyte Antigen 96
dc.subjectMice
dc.subjectPhosphates
dc.subjectProtein Conformation
dc.subjectReceptors, Interleukin
dc.subjectSignal Transduction
dc.subjectT-Lymphocytes
dc.subjectToll-Like Receptor 4
dc.subjectImmunology and Infectious Disease
dc.titleImmunology. The shape of things to come
dc.typeJournal Article
dc.source.journaltitleScience (New York, N.Y.)
dc.source.volume316
dc.source.issue5831
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/infdis_pp/81
dc.identifier.contextkey1901404
html.description.abstract<p>Mechanistic understanding of how ligands can fine-tune the immune response may lead to better vaccine adjuvants.</p>
dc.identifier.submissionpathinfdis_pp/81
dc.contributor.departmentDepartment of Medicine, Division of Infectious Diseases and Immunology
dc.source.pages1574-6


This item appears in the following Collection(s)

Show simple item record